Io in Humanitas
Unità
Servizio di Medicina Nucleare
Ruolo in Ospedale
Responsabile Servizio di Medicina Nucleare
Specializzazione
Medicina Nucleare
Area Medica
Medicina Nucleare
Esperienze precedenti
Ultima esperienza lavorativa
Dal 2006 al 2007
Istituto Europeo di Oncologia – IEO
Specialista in Medicina Nucleare
Formazione
Laurea
Corso di Laurea in Medicina e Chirurgia
Anno di laurea: 2000
Università: Università degli Studi di Messina
Specializzazione
Specializzazione in Medicina Nucleare
Anno di specializzazione: 2005
Università: Università degli Studi di Messina
Attività e Pubblicazioni Scientifiche
- Sierra ML, Agazzi A, Bodei L, Pacifici M, Aricò D, De Cicco C, Quarna J, Sansovini M, De Simone M, Paganelli G. Lymphocytic toxicity in patients after peptide-receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE and 90Y-DOTATOC. Cancer Biother Radiopharm. 2009 Dec;24(6):659-65
- Aricò D, Grana CM, Vanazzi A, Ferrari M, Mallia A, Sansovini M, Martinelli G, Paganelli G, Cremonesi M.The role of dosimetry in the high activity 90Y-ibritumomab tiuxetan regimens: two cases of abnormal biodistribution. Cancer Biother Radiopharm. 2009 Apr;24(2):271-5
- Bartolomei M, Bodei L, De Cicco C, Grana CM, Cremonesi M, Botteri E, Baio S, Aricò D, Sansovini M, Paganelli G.Peptide receptor radionuclide therapy with (90)Y-DOTATOC in recurrent meningioma.Eur J Nucl Med Mol Imaging. 2009 Mar 25.
- Cremonesi M, Ferrari M, Bartolomei M, Orsi F, Bonomo G, Aricò D, Mallia A, De Cicco C, Pedroli G, Paganelli G.Radioembolisation with (90)Y-microspheres: dosimetric and radiobiological investigation for multi-cycle treatment. Eur J Nucl Med Mol Imaging. 2008 Jul 10;
- Minutoli F, Herberg A, Spadaro P, Restifo Pecorella G, Baldari Sa, Aricò D, Altavilla G, Baldari S.186Re-HEDP in the Palliation of Painful Bone Metastases from Cancers Other Than Prostate and Breast. Q J Nucl Med; Published by Italian Association of Nuclear Medicine.
- Minutoli F, Angileri FF, Conti A, Herberg A, Aricò D, Baldari Sa, Cardali S, de Divitiis O, Germanò A, Baldari S.Timing of the examination affects the reliability of 99mTc-MIBI SPECT in distinguishing neoplastic from non-neoplastic brain hematomas. J Nucl Med. 2005 Apr;46(4):574-9. I.F.=4,899
- Aricò D, Macrì P, Bambaci M, Leone G, Romano D, Barbagallo F, Maria S, Picone A, Carnaghi C, Piazza D, Gozzo C, Evangelista L, Gebbia V. Non-palpable Pulmonary Nodules and Uniportal-VATS: Radio-guided Localization (ROLL) Experience of a Lung Multidisciplinary Team. Anticancer Res. 2024 Aug;44(8):3507-3514. doi: 10.21873/anticanres.17171. PubMed PMID: 39060087.
- Aricò D, Giacoppo G, Bambaci M, Marino L, Girlando A, Sortino G, Leone G, Fernandes B, Alì M, Evangelista L, Romano A. 18 F-FET PET/CT in Calcifying Pseudoneoplasm of the Neuraxis : First Case. Clin Nucl Med. 2024 Jun 1;49(6):e272-e273. doi: 10.1097/RLU.0000000000005197. Epub 2024 Mar 25. PubMed PMID: 38537205.
- Bianchi A, De Rimini ML, Sciuto R, Annovazzi A, Di Traglia S, Bauckneht M, Lanfranchi F, Morbelli S, Nappi AG, Ferrari C, Rubini G, Panareo S, Urso L, Bartolomei M, D’Arienzo D, Valente T, Rossetti V, Caroli P, Matteucci F, Aricò D, Bombaci M, Caponnetto D, Bertagna F, Albano D, Dondi F, Gusella S, Spimpolo A, Carriere C, Balma M, Buschiazzo A, Gallicchio R, Storto G, Ruffini L, Scarlattei M, Baldari G, Cervino AR, Cuppari L, Burei M, Trifirò G, Brugola E, Zanini CA, Alessi A, Fuoco V, Seregni E, Deandreis D, Liberini V, Moreci AM, Ialuna S, Pulizzi S, Evangelista L. Can Baseline [(18)F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study. Cancer Biother Radiopharm. 2023 May;38(4):256-267. doi: 10.1089/cbr.2022.0092. Epub 2023 Apr 25. PubMed PMID: 37098169.
- Sapuppo G, Giusti MA, Aricò D, Masucci R, Tavarelli M, Russo M, Pellegriti G. Recurrent parathyromatosis in a patient with concomitant MEN1 and CASR gene alterations: Clinical management of a case report and literature review. Front Endocrinol (Lausanne). 2023;14:1108278. doi: 10.3389/fendo.2023.1108278. eCollection 2023. Review. PubMed PMID: 36998475; PubMed Central PMCID: PMC10044612.
- Evangelista L, Bianchi A, Annovazzi A, Sciuto R, Di Traglia S, Bauckneht M, Lanfranchi F, Morbelli S, Nappi AG, Ferrari C, Rubini G, Panareo S, Urso L, Bartolomei M, D’Arienzo D, Valente T, Rossetti V, Caroli P, Matteucci F, Aricò D, Bombaci M, Caponnetto D, Bertagna F, Albano D, Dondi F, Gusella S, Spimpolo A, Carriere C, Balma M, Buschiazzo A, Gallicchio R, Storto G, Ruffini L, Cervati V, Ledda RE, Cervino AR, Cuppari L, Burei M, Trifirò G, Brugola E, Zanini CA, Alessi A, Fuoco V, Seregni E, Deandreis D, Liberini V, Moreci AM, Ialuna S, Pulizzi S, De Rimini ML. ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors. Cancers (Basel). 2023 Jan 31;15(3). doi: 10.3390/cancers15030878. PubMed PMID: 36765835; PubMed Central PMCID: PMC9913289.
- Valerio MR, Serretta V, Arico D, Fazio I, Altieri V, Baldari S, Pennisi M, Girlando A, Spada M, Gesolfo CS, Messina M, Messina C, Giorgia L, Sortino G, DI Grazia A, Guggino R, Borsellino N, Piazza D, Gebbia V. A Prospective Observational Study on the Structuring Process and Implementation of a Large Regional, Inter-hospital, Virtual Multidisciplinary Tumor Board on Prostate Cancer. Anticancer Res. 2023 Jan;43(1):501-508. doi: 10.21873/anticanres.16187. PubMed PMID: 36585190.
- Laudicella R, La Torre F, Davì V, Crocè L, Aricò D, Leonardi G, Russo S, Minutoli F, Burger IA, Baldari S. Prostate Cancer Biochemical Recurrence Resulted Negative on [(68)Ga]Ga-PSMA-11 but Positive on [(18)F]Fluoromethylcholine PET/CT. Tomography. 2022 Sep 30;8(5):2471-2474. doi: 10.3390/tomography8050205. PubMed PMID: 36287804; PubMed Central PMCID: PMC9609559.
- Laudicella R, Comelli A, Liberini V, Vento A, Stefano A, Spataro A, Crocè L, Baldari S, Bambaci M, Deandreis D, Arico’ D, Ippolito M, Gaeta M, Alongi P, Minutoli F, Burger IA, Baldari S. [(68)Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [(177)Lu]DOTATOC PRRT: The “Theragnomics” Concept. Cancers (Basel). 2022 Feb 16;14(4). doi: 10.3390/cancers14040984. PubMed PMID: 35205733; PubMed Central PMCID: PMC8870649.
- Arico’ D, Giardina C, Tuscano C, Picone A, Militano V. First case of (18)F-choline uptake in acoustic schwannoma after stereotactic radiotherapy. World J Nucl Med. 2019 Apr-Jun;18(2):187-188. doi: 10.4103/wjnm.WJNM_26_18. PubMed PMID: 31040753; PubMed Central PMCID: PMC6476238.
- Tuscano C, Vincelli ID, Arico’ D, Marchione AM, Versace P, Stelitano C, Porta N, Petrozza V, Di Cristofano C, Sceni G, Ronco F, Russi EG, Al Sayyad S. A rare case of appendicular skeleton localization in a patient with chronic lymphocytic leukemia successfully treated with salvage radiation therapy. Adv Radiat Oncol. 2018 Apr-Jun;3(2):121-124. doi: 10.1016/j.adro.2017.01.007. eCollection 2018 Apr-Jun. PubMed PMID: 29904735; PubMed Central PMCID: PMC6000042.
- Sierra ML, Agazzi A, Bodei L, Pacifici M, Aricò D, De Cicco C, Quarna J, Sansovini M, De Simone M, Paganelli G. Lymphocytic toxicity in patients after peptide-receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE and 90Y-DOTATOC. Cancer Biother Radiopharm. 2009 Dec;24(6):659-65. doi: 10.1089/cbr.2009.0641. PubMed PMID: 20025545.
- Bartolomei M, Bodei L, De Cicco C, Grana CM, Cremonesi M, Botteri E, Baio SM, Aricò D, Sansovini M, Paganelli G. Peptide receptor radionuclide therapy with (90)Y-DOTATOC in recurrent meningioma. Eur J Nucl Med Mol Imaging. 2009 Sep;36(9):1407-16. doi: 10.1007/s00259-009-1115-z. Epub 2009 Mar 25. PubMed PMID: 19319527.
- Aricò D, Grana CM, Vanazzi A, Ferrari M, Mallia A, Sansovini M, Martinelli G, Paganelli G, Cremonesi M. The role of dosimetry in the high activity 90Y-ibritumomab tiuxetan regimens: two cases of abnormal biodistribution. Cancer Biother Radiopharm. 2009 Apr;24(2):271-5. doi: 10.1089/cbr.2008.0541. PubMed PMID: 19409050.
- Cremonesi M, Ferrari M, Bartolomei M, Orsi F, Bonomo G, Aricò D, Mallia A, De Cicco C, Pedroli G, Paganelli G. Radioembolisation with 90Y-microspheres: dosimetric and radiobiological investigation for multi-cycle treatment. Eur J Nucl Med Mol Imaging. 2008 Nov;35(11):2088-96. doi: 10.1007/s00259-008-0857-3. Epub 2008 Jul 10. PubMed PMID: 18618108.
- Minutoli F, Herberg A, Spadaro P, Restifo Pecorella G, Baldari S, Aricò D, Altavilla G, Baldari S. [186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast. Q J Nucl Med Mol Imaging. 2006 Dec;50(4):355-62. PubMed PMID: 17043634.
- Minutoli F, Angileri FF, Conti A, Herberg A, Aricò D, Baldari S, Cardali S, de Divitiis O, Germanò A, Baldari S. Timing of examination affects reliability of 99mTc-methoxyisobutylisonitrile SPECT in distinguishing neoplastic from nonneoplastic brain hematomas. J Nucl Med. 2005 Apr;46(4):574-9. PubMed PMID: 15809478.